Table 2 Characteristics of recurrence and second debulking surgery
From: Salvage cytoreductive surgery for patients with recurrent endometrial cancer: a retrospective study
Number of patients (%) | |
|---|---|
Largest size of recurrence (cm) | |
Median (range) | 6 (1-25) |
Sites of recurrence | |
Central pelvic-vaginal | 6 (8.0) |
Pelvic | 25 (33.3) |
Intro-abdorminal alone | 3 (4.0) |
Retroperitoneal alone | 8 (10.7) |
Pelvic and intra-abdominal | 17 (22.7) |
Pelvic and retroperitoneal | 3 (4.0) |
Intra-abdominal and retroperitoneal | 1 (1.3) |
Vaginal | 5 (6.7) |
Inguinal | 5 (6.7) |
Abdominal wall | 1 (1.3) |
Lung | 1 (1.3) |
Ascites | 8 (10.5) |
Multiplicity of recurrence | |
Solitary | 35 (46.7) |
Multiple | 40 (53.3) |
Surgical procedures | |
Tumor mass resection | 36 (51.4) |
Pelvic lymph node resection | 12 (16.0) |
Para-aortic lymph node resection | 10 (13.3) |
Inguinal lymph node resection | 4 (5.3) |
Omentectomy | 17 (22.7) |
Appendectomy | 9 (12.0) |
Mesenterectomy | 5 (6.7) |
Large-bowel resection | 19 (25.0) |
Small-bowel resection | 6 (8.0) |
Colostomy | 6 (8.0) |
Patial abdominal wall resection | 3 (4.0) |
Upper vaginectomy | 18 (24.0) |
Vulvectomy | 1 (1.3) |
Partial urethrectomy | 1 (1.3) |
Partial cystectomy and ureterectomy | 2 (2.7) |
Ureteral stents | 6 (8.0) |
Partial gastrectomy | 1 (1.3) |
Radical pulmonary lobe resection | 1 (1.3) |
Biopsy alone | 4 (5.3) |
Operative time (minutes) | |
Median (range) | 150 (30-430) |
Blood transfusion | 42 (56.0) |
Median (range, blood unit) | 2 (1-13) |
Median hospitalized day | 20 (6-130) |
Residual disease (cm) | |
None | 43 (57.3) |
0.1~1 | 15 (20.0) |
1~2 | 6 (8.0) |
>2 | 11 (14.7) |
Complications | 9 (12.0) |
Iliac artery injury | 1 (1.33) |
Ureteral injury | 2 (2.67) |
Acute renal failure | 1 (1.33) |
Urethrovaginal fistula | 1 (1.33) |
Bowel obstruction | 1 (1.33) |
Deep vein thrombosis | 1 (1.33) |
Drug allergy | 1 (1.33) |
Hydronephrosis | 1 (1.33) |